Connect with us

JAMMU & KASHMIR

DAK skeptical of Russian COVID-19 vaccine | KNO

Published

on

kno news

Srinagar, Aug 12 (KNO): While Russia has approved the world’s first COVID-19 vaccine for public use, Doctors Association Kashmir (DAK) on Wednesday said they are skeptical about the claim as the vaccine has been granted license for civilian use even before the clinical trials are completed. “Mass vaccination with an incompletely tested vaccine is unethical,” said DAK President and influenza expert Dr Nisar ul Hassan in a statement issued to the news agency—Kashmir News Observer (KNO). “Russia has conducted just two trials of the vaccine with the third clinical trial yet to start,” he said. “The normal approval process of a new vaccine is to gather data from phase 1 and phase 2 clinical trials and then expand the pool of study participants in phase 3 to create enough evidence that the vaccine is effective and safe. Dr Nisar said to fully assess the efficacy and safety of a vaccine phase 3 trials are required. “The phase 3 trial is the pivotal study on which the decision on whether to grant the license is based,” he said. He said Russia has not made data from the earlier trials public and the data has not been peer-reviewed which is important for regulatory approval. “Lack of published data on vaccine - including how it is made and details on safety, immune response and whether it can prevent COVID-19 infection has left health experts and the public across the globe in dark,” he added. Dr Nisar said the rush to start using the vaccine before phase 3 trials, which normally lasts for months and involve thousands of people could backfire. “One of the biggest concerns about approving a new vaccine before clinical trials are complete is that it could jeopardize public trust in the vaccine development process and people may not use it,” he said. “Even the Moscow-based Association of Clinical Trials Organization, a trade body representing the world’s top drug makers in Russia had urged the Russian health ministry to postpone vaccine approval until the final trial is successfully completed. The World Health Organization has made it clear that any WHO stamp of approval on Russia’s COVID-19 vaccine would require a rigorous safety data review,” said Dr Nisar—(KNO) 

Trending

TOP STORIES2 hours ago

Kashmir free of India-born terrorists now: Amit Shah | KNO

TOP STORIES2 hours ago

Tax not burden but contribution to nation building: PCIT Monika Dhami | KNO

TOP STORIES2 hours ago

Tourist arrivals swelling in Kashmir: Director Tourism | KNO

TOP STORIES2 hours ago

Chief Secy Dr Sajjan Singh Yadav begins his stint by visiting Jammu streets | KNO

TOP STORIES2 hours ago

Shopian records coldest night at –3.4°C as temps dip across Kashmir | KNO

TOP STORIES2 hours ago

PG, Senior Resident doctors’ stipend protest spreads to four more GMCs | KNO

TOP STORIES2 hours ago

COPD poses serious respiratory health challenges in Kashmir: Doctors | KNO

TOP STORIES3 hours ago

Two-day national conference on AI, media representation concludes at KU | KNO

TOP STORIES3 hours ago

84 judicial officers transferred in J&K, Ladakh High Court reshuffle | KNO

TOP STORIES3 hours ago

Leopard scare returns to Baramulla as 12 sheep killed, 3 carcasses found | KNO

TOP STORIES3 hours ago

Govt committed to dismantle terror ecosystem through decisive action: LG Sinha | KNO

TOP STORIES3 hours ago

J&K Govt begins reconstitution of child welfare committees | KNO

TOP STORIES3 hours ago

Power Puzzle: Why Is J&K projecting lower peak demand than last year's 3.3 GW | KNO

TOP STORIES3 hours ago

India, Japan vow stronger action against cross-border terrorism | KNO

TOP STORIES3 hours ago

In a first, organs retrieved from brain-dead Reasi man, flown to Delhi | KNO

TOP STORIES3 hours ago

SED announces provisional admission for Classes 11, 12 | KNO

TOP STORIES3 hours ago

Traffic snarls continue across Srinagar, DIG flags rising vehicle numbers | KNO

Copyright © 2021